Loss of PTEN is commonly found in endometrial cancer and hyperplasia with cell dysplasia [144,145,146,147], which reinforces that CCND1 overexpression can be used as a marker for the early development of endometrial cancer. This evidence concerns the gene PTEN and endometrial cancer.